TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA September 23, 1983
TCL Archive Duke Vice Dean Cuffe Promises Complete, Independent Probe Of Work By Potti, Nevins. July 30, 2010
TCL Archive NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway. January 27, 2006
